Binovi Technologies (OTCMKTS:BNVIF – Get Free Report) and OptimizeRx (NASDAQ:OPRX – Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, earnings, valuation and risk.
Analyst Recommendations
This is a summary of current ratings for Binovi Technologies and OptimizeRx, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Binovi Technologies | 0 | 0 | 0 | 0 | 0.00 |
| OptimizeRx | 1 | 2 | 6 | 0 | 2.56 |
OptimizeRx has a consensus target price of $11.43, suggesting a potential upside of 46.33%. Given OptimizeRx’s stronger consensus rating and higher possible upside, analysts clearly believe OptimizeRx is more favorable than Binovi Technologies.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| Binovi Technologies | N/A | N/A | N/A |
| OptimizeRx | 4.66% | 9.44% | 7.11% |
Valuation & Earnings
This table compares Binovi Technologies and OptimizeRx”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Binovi Technologies | N/A | N/A | N/A | N/A | N/A |
| OptimizeRx | $109.43 million | 1.34 | $5.13 million | $0.23 | 33.96 |
OptimizeRx has higher revenue and earnings than Binovi Technologies.
Institutional & Insider Ownership
76.5% of OptimizeRx shares are held by institutional investors. 7.5% of OptimizeRx shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Summary
OptimizeRx beats Binovi Technologies on 9 of the 9 factors compared between the two stocks.
About Binovi Technologies
Binovi Technologies Corp. engages in the development, manufacturing, and commercialization of visual and neuro-cognitive processing products, and hardware and software for diagnosing and remediating visual perception disorders in Canada, the United States, and internationally. The company's products include Binovi Touch, a tool for vision therapy and vision training; Binovi Pro, which allows doctors/trainers to manage various aspects of patient/athlete's vision training regimens, track progress, and plan and assign protocols; Binovi Coach, a tool that allows users to complete their assigned activities through clear multimedia guidance; and Binovi Academy, an educational hub. The company's products under development includes Binovi Connect, a web-based video conferencing solution that connects consumers to vision care professionals. The company was formerly known as Eyecarrot Innovations Corp. and changed its name to Binovi Technologies Corp. in June 2020. Binovi Technologies Corp. is based in Vancouver, Canada.
About OptimizeRx
OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.
Receive News & Ratings for Binovi Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Binovi Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
